Tender detail
Antihemorrhagics 2026 – Complex of coagulation factors IX, II, VII and X
Summary
This tender concerns the ongoing supply of medicinal products containing coagulation factors IX, II, VII and X for a period of four years according to the contracting authority's needs.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.